Table 1.
Study isolates.
| Source of isolation, number of isolates | % of all cases | Number with clinically significant growth (%) |
|---|---|---|
| Total number, 197 | 100% | 71 (36%) |
| Upper extremity, including hardware and native joints, 36 | 18% | 24 (67%) |
| Lower extremity, 51 | 26% | 7 (14%) |
| Spine/vertebral hardware, 45 | 23% | 25 (49%) |
| Breast implant, 49 | 25% | 9 (18%) |
| Penile implant, 7 | 4% | 1 (14%) |
| Cardiac valve, 3 | 2% | 2 (67%) |
| Blood, 1 | 1% | 1 (100%) |
| Pacemaker, 5 | 3% | 2 (40%) |
The table shows the site of isolation of the study isolates and whether they were considered to represent clinically significant growth (i.e., not contaminants).